The immunophenotype of SOCS1 mutant DLBCL was characterized by presence of BCL2 (18/24, 75.0%) and BCL6 expression (23/23, 100.0% of evaluable cases). This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.